![Duncan Peyton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Duncan Peyton
Gründer bei
Aquarius Equity Partners Ltd.
Profil
Duncan Peyton was the founder of Aquarius Equity Partners Ltd. (founded in 2005) and 4D Pharma Plc (founded in 2014), where he holds the titles of Director and CEO, Secretary & Executive Director respectively.
He also held former positions as an Independent Non-Executive Director at hVIVO Ltd. from 2012 to 2014, Director at GT Biologics Ltd., Non-Executive Director at C4X Discovery Ltd., and Investment Manager at 3i Plc.
Additionally, he had a former job at Addleshaw Booth & Co. from 2004 to 2007.
Mr. Peyton's education history includes an undergraduate degree from the University of Sunderland.
Aktive Positionen von Duncan Peyton
| Unternehmen | Position | Beginn |
|---|---|---|
Aquarius Equity Partners Ltd.
 Aquarius Equity Partners Ltd. Investment ManagersFinance Aquarius Equity Partners invests in early-stage companies located in the North of England with innovative and high growth potential. Aquarius Equity Partners provides financing for restructuring, traditional management buyouts, acquisitions and growth capital requirements. Aquarius Equity Partners Ltd is an independent private equity firm located in the UK. | Gründer | 01.01.2005 |
Ehemalige bekannte Positionen von Duncan Peyton
| Unternehmen | Position | Ende |
|---|---|---|
| 4D PHARMA PLC | Gründer | 16.03.2023 |
| HVIVO PLC | Direktor/Vorstandsmitglied | 21.05.2014 |
3i Plc
 3i Plc Financial ConglomeratesFinance Private equity firm and provides investment advice | Chief Investment Officer | - |
GT Biologics Ltd.
 GT Biologics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Direktor/Vorstandsmitglied | - |
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery and development of medical drugs | Direktor/Vorstandsmitglied | - |
Ausbildung von Duncan Peyton
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
26
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
hVIVO Holdings Ltd.
 hVIVO Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
University of Sunderland
 University of Sunderland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
3i Plc
3i Plc Financial ConglomeratesFinance Private equity firm and provides investment advice | Finance |
Aquarius Equity Partners Ltd.
Aquarius Equity Partners Ltd. Investment ManagersFinance Aquarius Equity Partners invests in early-stage companies located in the North of England with innovative and high growth potential. Aquarius Equity Partners provides financing for restructuring, traditional management buyouts, acquisitions and growth capital requirements. Aquarius Equity Partners Ltd is an independent private equity firm located in the UK. | Finance |
GT Biologics Ltd.
GT Biologics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
C4X Discovery Ltd.
C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery and development of medical drugs | Health Technology |
4D Pharma Plc
 4D Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which engages in the development of live bio therapeutics | Health Technology |
